LoPriore Vincent S has filed 3 insider transactions across 2 companies since November 2025.
Most recent transaction: a purchase of 5000000 shares of Hepion Pharmaceuticals, Inc. ($HEPA) on April 21, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 21, 2026 | Hepion Pharmaceuticals, Inc. | $HEPA | LoPriore Vincent S | Executive Chairman | P | Common Stock, par value $0.0001 per share | 5000000 | $0.04 | 11,250,000.0000 | 11,620,317 | 80.00% | 43.03% |
| April 21, 2026 | Hepion Pharmaceuticals, Inc. | $HEPA | LoPriore Vincent S | Executive Chairman | P | Common Stock, par value $0.0001 per share | 1250000 | $0.04 | 11,250,000.0000 | 11,620,317 | 12.50% | 10.76% |
| Nov. 3, 2025 | Canton Strategic Holdings, Inc. | $CNTN | LoPriore Vincent S | Executive Chairman | A | Stock Option | 90000 | $0.00 | 190,000.0000 | 2,108,753 | 90.00% | 4.27% |